Amount$60M
SeriesSeries A
AnnouncedFeb 11, 2021
Time since last round266 mo
SectorHealthcare, Immunology, Data, Analytics, Personalized Treatment, Drug Development, Computational Biology, Life Sciences, Therapeutics
Sub-sectorArtificial Intelligence, Machine Learning, Deep Learning
Solid
A solid round with healthy fundamentals.
Round size vs peers
Far above the typical Series A round (5.5× the median) — an outlier.
Syndicate size
Healthy syndicate of 6 investors.
Insider conviction
2 existing investors re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series A rounds (995)
Round size distribution93th pct
smaller Series A roundslarger
